225 related articles for article (PubMed ID: 27923035)
1. Biomarkers in anal cancer: from biological understanding to stratified treatment.
Jones CM; Goh V; Sebag-Montefiore D; Gilbert DC
Br J Cancer; 2017 Jan; 116(2):156-162. PubMed ID: 27923035
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
Cabel L; Jeannot E; Bieche I; Vacher S; Callens C; Bazire L; Morel A; Bernard-Tessier A; Chemlali W; Schnitzler A; Lièvre A; Otz J; Minsat M; Vincent-Salomon A; Pierga JY; Buecher B; Mariani P; Proudhon C; Bidard FC; Cacheux W
Clin Cancer Res; 2018 Nov; 24(22):5767-5771. PubMed ID: 30054279
[No Abstract] [Full Text] [Related]
3. Anal squamous cell carcinoma - State of the art management and future perspectives.
Martin D; Balermpas P; Winkelmann R; Rödel F; Rödel C; Fokas E
Cancer Treat Rev; 2018 Apr; 65():11-21. PubMed ID: 29494827
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma of the anal canal.
Zaleski L; Turiansky GW
Cutis; 2010 Mar; 85(3):143-5. PubMed ID: 20408513
[TBL] [Abstract][Full Text] [Related]
5. Anal cancer, anal squamous intraepithelial lesions and the genitourinary medicine specialist.
Manavi K; McMillan A
Int J STD AIDS; 2004 Mar; 15(3):153-9; quiz 160-1. PubMed ID: 15038859
[No Abstract] [Full Text] [Related]
6. Surveillance of Anal Canal Cancers.
Adams R
Surg Oncol Clin N Am; 2017 Jan; 26(1):127-132. PubMed ID: 27889031
[TBL] [Abstract][Full Text] [Related]
7. The immune microenvironment and HPV in anal cancer: Rationale to complement chemoradiation with immunotherapy.
Martin D; Rödel F; Balermpas P; Rödel C; Fokas E
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):221-230. PubMed ID: 28501560
[TBL] [Abstract][Full Text] [Related]
8. Anal cancer: are we making progress?
Aggarwal A; Duke S; Glynne-Jones R
Curr Oncol Rep; 2013 Apr; 15(2):170-81. PubMed ID: 23371446
[TBL] [Abstract][Full Text] [Related]
9. Anal cancer: progress on combined-modality and organ preservation.
Chan E; Kachnic LA; Thomas CR
Curr Probl Cancer; 2009; 33(5):302-26. PubMed ID: 20082844
[No Abstract] [Full Text] [Related]
10. Current treatment of anal squamous cell carcinoma.
Glynne-Jones R; Renehan A
Hematol Oncol Clin North Am; 2012 Dec; 26(6):1315-50. PubMed ID: 23116582
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of anal cancer.
Gervaz P; Buchs N; Morel P
Curr Gastroenterol Rep; 2008 Oct; 10(5):502-6. PubMed ID: 18799127
[TBL] [Abstract][Full Text] [Related]
14. The Management and Prevention of Anal Squamous Cell Carcinoma.
Eng C; Messick C; Glynne-Jones R
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():216-225. PubMed ID: 31099616
[TBL] [Abstract][Full Text] [Related]
15. Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer.
Koerber SA; Schoneweg C; Slynko A; Krug D; Haefner MF; Herfarth K; Debus J; Sterzing F; von Knebel Doeberitz M; Prigge ES; Reuschenbach M
Radiother Oncol; 2014 Dec; 113(3):331-6. PubMed ID: 25465729
[TBL] [Abstract][Full Text] [Related]
16. Squamous rectal carcinoma: a rare malignancy, literature review and management recommendations.
Astaras C; Bornand A; Koessler T
ESMO Open; 2021 Aug; 6(4):100180. PubMed ID: 34111760
[TBL] [Abstract][Full Text] [Related]
17. Images in HIV/AIDS. The changing face of anal cancer.
Romassi M; Nagle D
AIDS Read; 2008 Apr; 18(4):185-7. PubMed ID: 18472440
[No Abstract] [Full Text] [Related]
18. [Multidisciplinary Treatment for Squamous Cell Carcinoma of the Anal Canal].
Karasawa H; Ohnuma S; Watanabe K; Tsuchiya T; Imoto H; Aoki T; Kudoh K; Tanaka N; Nagao M; Abe T; Musha H; Motoi F; Kamei T; Naitoh T; Unno M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):2009-2010. PubMed ID: 29394850
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma of the anal canal.
Morton M; Melnitchouk N; Bleday R
Curr Probl Cancer; 2018 Sep; 42(5):486-492. PubMed ID: 30497849
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]